Injury of Optic Nerve
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Phase I Study of Recombinant Human Nerve Growth Factor Injection (NCT04232332) | Beijing Tongren Hospital | 2019-12-26 |
Track Injury of Optic Nerve automatically
Every clearance here is in the API, with alerts when new ones post.